{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:38:34Z","timestamp":1773286714356,"version":"3.50.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.trim.2005.03.009","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T11:41:32Z","timestamp":1114602092000},"page":"207-219","source":"Crossref","is-referenced-by-count":31,"title":["Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"I.B.","family":"Resnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Y.","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7583","key":"10.1016\/j.trim.2005.03.009_bib1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","article-title":"Immunological reconstitution of sex-linked lymphopenic immunological deficiency","volume":"2","author":"Gatti","year":"1968","journal-title":"Lancet"},{"issue":"7583","key":"10.1016\/j.trim.2005.03.009_bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(68)92672-X","article-title":"Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome","volume":"2","author":"Bach","year":"1968","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.trim.2005.03.009_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-065X.2002.18513.x","article-title":"Cellular immunology in a historical perspective","volume":"185","author":"Good","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trim.2005.03.009_bib4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","article-title":"Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia","volume":"73","author":"Sullivan","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.trim.2005.03.009_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.trim.2005.03.009_bib6","first-page":"2989","article-title":"Graft-versus-leukemia reactions in humans","volume":"21","author":"Ringden","year":"1989","journal-title":"Transplant Proc"},{"issue":"9134","key":"10.1016\/j.trim.2005.03.009_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","article-title":"Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"352","author":"Gratwohl","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2005.03.009_bib8","series-title":"Clinical transplants","first-page":"117","article-title":"Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry\u2014North America","author":"Passweg","year":"1995"},{"key":"10.1016\/j.trim.2005.03.009_bib9","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2005.03.009_bib11","first-page":"301a","article-title":"Engraftment and induction of GVL with fludarabine based non-ablative preparative regimens in patients with chronic lymphocytic leukemia and lymphoma","volume":"88","author":"Khouri","year":"1996","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2005.03.009_bib12","first-page":"519a","article-title":"Outpatient PBSC allografts using immunosuppression with low-dose TBI before, and cyclosporine (CSP) and mycophenolate mofetil (MMF) after transplant","volume":"92","author":"McSweeney","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","article-title":"\u201cMini-allografts\u201d: ongoing trials in humans","volume":"25","author":"Carella","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib14","first-page":"304","article-title":"Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia","volume":"85","author":"Carella","year":"2000","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bmt.1704190","article-title":"A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation","volume":"32","author":"Shapira","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.bmt.1704540","article-title":"Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients","volume":"34","author":"Shapira","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"14","key":"10.1016\/j.trim.2005.03.009_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation","volume":"343","author":"Childs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trim.2005.03.009_bib18","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.1999.17.7.2044","article-title":"Successful treatment of metastatic renal cell carcinoma with a non-myeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect","volume":"17","author":"Childs","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib19","first-page":"1","article-title":"Allogeneic cell mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study","author":"Or","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.trim.2005.03.009_bib20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501","article-title":"Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer","volume":"88","author":"Eibl","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.trim.2005.03.009_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1200\/JCO.1998.16.3.986","article-title":"Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer","volume":"16","author":"Ueno","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trim.2005.03.009_bib22","first-page":"181","article-title":"In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic-T cell activities","volume":"10","author":"Van Lochem","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trim.2005.03.009_bib23","first-page":"153","article-title":"The role of non-activated and rIL-2 activated CD4+ and CD8+ T cells in immunotherapy for leukemia","volume":"5","author":"Weiss","year":"1999","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.trim.2005.03.009_bib24","first-page":"789","article-title":"Effect of deoxyspergualin on graft vs. host disease and graft vs. leukemia in mice","volume":"17","author":"Weiss","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00007890-199508270-00010","article-title":"The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation","volume":"60","author":"Palathumpat","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2005.03.009_bib26","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.3052.3052","article-title":"Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease","author":"Maeda","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.trim.2005.03.009_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.TP.0000110416.96307.D5","article-title":"Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients","volume":"77","author":"Marks","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2005.03.009_bib28","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V86.11.4337.bloodjournal86114337","article-title":"CD8-depleted donor lymphocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation","volume":"86","author":"Giralt","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.trim.2005.03.009_bib29","first-page":"391","article-title":"Hematologic relapse of chronic myelogenous leukemia following abrupt discontinuation of immunosuppression","volume":"10","author":"Collins","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib30","first-page":"457","article-title":"The role of antibodies to IL-2 receptor and anti-Asialo GMI antibodies on GVL effects induced by BMT in murine B cell leukemia","volume":"16","author":"Weiss","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trim.2005.03.009_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-2776(08)60778-6","article-title":"Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells","volume":"49","author":"Greenberg","year":"1991","journal-title":"Adv Immunol"},{"key":"10.1016\/j.trim.2005.03.009_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2141.1997.d01-2101.x","article-title":"Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukemia effect in mice","volume":"96","author":"Zeis","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trim.2005.03.009_bib33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.trim.2005.03.009_bib34","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2005.03.009_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0952-7915(97)80051-9","article-title":"HLA class I specific inhibitory receptors","volume":"9","author":"Moretta","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trim.2005.03.009_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trim.2005.03.009_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1074-7613(95)90025-X","article-title":"Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intra-cellular domains","volume":"2","author":"Wagtmann","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.trim.2005.03.009_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.7716543","article-title":"Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells","volume":"268","author":"Colonna","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.trim.2005.03.009_bib39","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4049\/jimmunol.155.5.2306","article-title":"Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes","volume":"155","author":"D'Andrea","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.trim.2005.03.009_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.trim.2005.03.009_bib41","first-page":"81","article-title":"Treatment of myeloid leukemias with non-myeloablative stem cell transplantation: accomplishments and future goals","author":"Slavin","year":"2000","journal-title":"Hematology"},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2005.03.009_bib42","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s002800100311","article-title":"Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders: past accomplishments and future goals","volume":"48","author":"Slavin","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.trim.2005.03.009_bib43","series-title":"Cancer chemotherapy and biological response modifiers. Annual 20. Chapter 13","first-page":"291","article-title":"Donor lymphocyte infusions for hematopoietic malignancy","author":"Slavin","year":"2002"},{"issue":"9","key":"10.1016\/j.trim.2005.03.009_bib44","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0301-472X(00)00511-7","article-title":"Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation","volume":"28","author":"Nagler","year":"2000","journal-title":"Exp Hematol"},{"issue":"10","key":"10.1016\/j.trim.2005.03.009_bib45","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","article-title":"Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for a malignant lymphoma","volume":"25","author":"Nagler","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2002-02-0535","article-title":"Non-myeloablative allogeneic stem call transplantation for the treatment of chronic myeloid leukemia in first chronic phase","volume":"101","author":"Or","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002371-200103000-00005","article-title":"Cell therapy with pre-immunized effector cells mismatched for minor histocompatible antigens, in the treatment of a murine mammary carcinoma","volume":"24","author":"Morecki","year":"2001","journal-title":"J Immunother"},{"key":"10.1016\/j.trim.2005.03.009_bib48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.132.2.997","article-title":"Anti-tumor effects of allogeneic bone marrow transplantation in (NZB\u00d7NZW)F1 hybrids with spontaneous lymphosarcoma","volume":"132","author":"Moscovitch","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2005.03.009_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<59::AID-IJC11>3.0.CO;2-4","article-title":"Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma","volume":"71","author":"Morecki","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trim.2005.03.009_bib50","first-page":"3891","article-title":"Allogeneic cell therapy for a murine mammary carcinoma","volume":"58","author":"Morecki","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.trim.2005.03.009_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.1992.10.2.180","article-title":"The immunotherapy and gene therapy of cancer","volume":"10","author":"Rosenberg","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trim.2005.03.009_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.iy.04.040186.003341","article-title":"Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes","volume":"4","author":"Rosenberg","year":"1986","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.trim.2005.03.009_bib53","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood-2003-04-1022","article-title":"Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors","volume":"102","author":"Ueno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trim.2005.03.009_bib54","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0022-5347(05)66479-8","article-title":"Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma","volume":"165","author":"Rini","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.trim.2005.03.009_bib55","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2002.08.068","article-title":"Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results","volume":"20","author":"Rini","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trim.2005.03.009_bib56","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.10491","article-title":"Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies","volume":"94","author":"Pedrazzoli","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.trim.2005.03.009_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1703811","article-title":"Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma","volume":"31","author":"Hentschke","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trim.2005.03.009_bib58","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1182\/blood.V99.11.4234","article-title":"Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer","volume":"99","author":"Bregni","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.trim.2005.03.009_bib59","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/sj.bmt.1703287","article-title":"A graft-versus-colonic cancer effect of allogeneic stem cell transplantation","volume":"28","author":"Zetterquist","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trim.2005.03.009_bib60","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.trim.2005.03.009_bib61","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2004.01.127","article-title":"Allogenic lymphocytes induce tumor regression of advanced metastatic breast cancer","volume":"22","author":"Bishop","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trim.2005.03.009_bib62","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/annonc\/mdh142","article-title":"Hematopoetic stem cell transplantation for solid tumors in Europe","volume":"15","author":"Gratwohl","year":"2004","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1701903","article-title":"Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease","volume":"24","author":"Nagler","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.trim.2005.03.009_bib64","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bmt.1701016","article-title":"Fludarabine based protocol for BMT in Fanconi anemia","volume":"29","author":"Kapelushnik","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bmt.1704580","article-title":"Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors","volume":"34","author":"Maschan","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.trim.2005.03.009_bib66","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.bmt.1704219","article-title":"Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors","volume":"32","author":"de la Fuente","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.trim.2005.03.009_bib67","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood.V84.6.2050.2050","article-title":"Bone marrow transplantation in Fanconi anemia using matched sibling donors","volume":"84","author":"Kohli-Kumar","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib68","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-2141.2001.02572.x","article-title":"Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO","volume":"112","author":"Dufour","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.trim.2005.03.009_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1704340","article-title":"Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation","volume":"33","author":"Ayas","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.trim.2005.03.009_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bmt.1701758","article-title":"The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases","volume":"23","author":"Rosales","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1468-0734.2001.00036.x","article-title":"Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders","volume":"5","author":"Slavin","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"issue":"1\u20132","key":"10.1016\/j.trim.2005.03.009_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1040-8428(01)00121-4","article-title":"Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases","volume":"39","author":"Slavin","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-0502(02)00038-1","article-title":"Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals","volume":"27","author":"Slavin","year":"2002","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.trim.2005.03.009_bib74","first-page":"275","article-title":"Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders","author":"Slavin","year":"2003","journal-title":"Clin Transpl"},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2005.03.009_bib75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF03165240","article-title":"Maternal\u2013fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation","volume":"76","author":"Slavin","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trim.2005.03.009_bib76","series-title":"Non-myeloablative stem cell transplantation (NST)","first-page":"127","article-title":"Non-myeloablative stem cell transplantation for non-malignant disorders","author":"Or","year":"2000"},{"issue":"1\u20132","key":"10.1016\/j.trim.2005.03.009_bib77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00281-004-0169-z","article-title":"Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products","volume":"26","author":"Or","year":"2004","journal-title":"Springer Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000216399","article-title":"Aplastic anemia: pathogenesis and treatment","volume":"10","author":"Bacigalupo","year":"1987","journal-title":"Onkologie"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib79","first-page":"304","article-title":"Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy","volume":"11","author":"Halperin","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib80","first-page":"211","article-title":"Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party","volume":"6","author":"Locasciulli","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib81","first-page":"273","article-title":"CY\/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors","volume":"18","author":"Tzeng","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.trim.2005.03.009_bib82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/blood.V85.1.283.bloodjournal851283","article-title":"Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation","volume":"85","author":"Paquette","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/0003-4819-126-2-199701150-00003","article-title":"Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team","volume":"126","author":"Doney","year":"1997","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib84","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/bbmt.1999.v5.pm10465104","article-title":"Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy","volume":"5","author":"Deeg","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2008-1043875","article-title":"Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German\/Austrian Pediatric Aplastic Anemia Working Group","volume":"210","author":"Fuhrer","year":"1998","journal-title":"Klin Padiatr"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib86","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1182\/blood.V64.2.325.325","article-title":"Acquired severe aplastic anemia: progress and perplexity","volume":"64","author":"Thomas","year":"1984","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2005.03.009_bib87","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.1993.tb03181.x","article-title":"Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party","volume":"85","author":"Schrezenmeier","year":"1993","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.trim.2005.03.009_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000041000","volume":"103","author":"Bacigalupo","year":"2000","journal-title":"Acta Haematol"},{"issue":"16","key":"10.1016\/j.trim.2005.03.009_bib89","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM199310143291603","article-title":"Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party","volume":"329","author":"Socie","year":"1993","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.trim.2005.03.009_bib90","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1073\/pnas.87.21.8341","article-title":"Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells","volume":"87","author":"Ikehara","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2005.03.009_bib91","first-page":"183","article-title":"Review: BMT in experimental autoimmune diseases","volume":"11","author":"Van Bekkum","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trim.2005.03.009_bib92","first-page":"333","article-title":"Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation","volume":"8","author":"Knaan-Shanzer","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trim.2005.03.009_bib93","first-page":"1029","article-title":"Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation","volume":"18","author":"Van Gelder","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/ar103","article-title":"Immune ablation and stem-cell therapy in autoimmune disease. Experimental basis for autologous stem-cell transplantation","volume":"2","author":"Bekkum","year":"2000","journal-title":"Arthritis Res"},{"issue":"1","key":"10.1016\/j.trim.2005.03.009_bib95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2004.04.021","article-title":"Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures","volume":"223","author":"Karussis","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.trim.2005.03.009_bib96","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.96.6.3012","article-title":"Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice","volume":"96","author":"Bingyan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2005.03.009_bib97","article-title":"Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and MHC-mismatched allogeneic bone marrow transplantation","author":"Flierman","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib98","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bcmd.2004.08.010","article-title":"Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients","volume":"33","author":"Prigozhina","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.trim.2005.03.009_bib99","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.1204.1204","article-title":"Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb","author":"Liang","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/bbmt.2001.v7.pm11302546","article-title":"Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities","volume":"7","author":"Good","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.trim.2005.03.009_bib101","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V95.5.1862.005k27_1862_1868","article-title":"Treatment of intractable autoimmune diseases in MRL\/lpr mice using a new strategy for allogeneic bone marrow transplantation","volume":"95","author":"Kushida","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1634\/stemcells.19-3-226","article-title":"Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in mrl\/lpr mice by BMT via portal vein","volume":"19","author":"Kushida","year":"2001","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.trim.2005.03.009_bib103","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/blood.V97.10.3292","article-title":"Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL\/lpr mice","volume":"97","author":"Kushida","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.trim.2005.03.009_bib104","first-page":"733","article-title":"Stem cell transplantation for severe autoimmune diseases: progress and problems","volume":"83","author":"Marmont","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.trim.2005.03.009_bib105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/38.8.757","article-title":"Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation","volume":"38","author":"Van Bekkum","year":"1999","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.trim.2005.03.009_bib106","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bmt.1700815","article-title":"Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma","volume":"19","author":"Snowden","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.trim.2005.03.009_bib107","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs. autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1016\/j.trim.2005.03.009_bib108","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s002680010128","article-title":"Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases","volume":"24","author":"Good","year":"2000","journal-title":"World J Surg"},{"issue":"5\u20136","key":"10.1016\/j.trim.2005.03.009_bib109","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000065308","article-title":"Mixed bone marrow or mixed stem cell transplantation for prevention or treatment of lupus-like diseases in mice","volume":"10","author":"Good","year":"2002","journal-title":"Exp Nephrol"},{"issue":"6","key":"10.1016\/j.trim.2005.03.009_bib110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.exphem.2004.03.007","article-title":"Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation","volume":"32","author":"Elkin","year":"2004","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib111","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.trim.2005.03.009_bib112","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1191\/0961203304lu525oa","article-title":"Autologous stem cell transplantation for systemic lupus erythematosus","volume":"13","author":"Jayne","year":"2004","journal-title":"Lupus"},{"issue":"Suppl. 1","key":"10.1016\/j.trim.2005.03.009_bib113","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF03165250","article-title":"Autologous stem cell transplants in treatment of multiple sclerosis: where we stand and future prospects","volume":"76","author":"Fassas","year":"2002","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.trim.2005.03.009_bib114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0268-960X(03)00022-5","article-title":"Stem cell transplantation for multiple sclerosis: what is the evidence?","volume":"17","author":"Fassas","year":"2003","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.trim.2005.03.009_bib115","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00415-002-0800-7","article-title":"Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study","volume":"249","author":"Fassas","year":"2002","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.trim.2005.03.009_bib116","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.2004.04978.x","article-title":"Haematopoetic stem cell transplantation for refractory autoimmune cytopenia","volume":"125","author":"Passweg","year":"2004","journal-title":"Br J Haematol"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327405000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327405000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T01:52:50Z","timestamp":1683078770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327405000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":116,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0966327405000389"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2005.03.009","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}